General practitioner assessment of stage and performance status in lung cancer patients at a population level: Implications for prognosis and radiotherapy needs analyses
- 30 September 2007
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 57 (3) , 381-388
- https://doi.org/10.1016/j.lungcan.2007.03.024
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS projectRadiotherapy and Oncology, 2005
- Clinical Model to Predict Survival in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Treated With Third-Generation Chemotherapy Regimens Based on Eastern Cooperative Oncology Group DataJournal of Clinical Oncology, 2005
- Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based studyLung Cancer, 2004
- Population-based outcomes for small cell lung cancer: impact of standard management policies in British ColumbiaLung Cancer, 2004
- A model for decision making for the use of radiotherapy in lung cancerThe Lancet Oncology, 2003
- Factors Influencing the Use of Thoracic Radiotherapy in Lung Cancer—an Analysis of the 1995 Scottish Lung Cancer AuditClinical Oncology, 2002
- Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based studyThorax, 2001
- Prognostic Assessment of 2,361 Patients Who Underwent Pulmonary Resection for Non-small Cell Lung Cancer, Stage I, II, and IIIAChest, 2000
- Impact of Revised Stage Classification of Lung Cancer on SurvivalChest, 1999
- Age and the treatment of lung cancer.Thorax, 1996